Ozempic is massively threatening the established diet industry — and it appears that Weight Watchers is now getting the ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes.

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.